Axcelis Technologies, Inc. Stock

Equities

ACLS

US0545402085

Semiconductor Equipment & Testing

Market Closed - Nasdaq 04:00:00 2024-05-31 pm EDT 5-day change 1st Jan Change
112.5 USD -1.05% Intraday chart for Axcelis Technologies, Inc. +1.01% -13.26%
Sales 2024 * 1.05B Sales 2025 * 1.23B Capitalization 3.66B
Net income 2024 * 201M Net income 2025 * 263M EV / Sales 2024 * 3.49 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 2.98 x
P/E ratio 2024 *
18 x
P/E ratio 2025 *
13.9 x
Employees 1,620
Yield 2024 *
-
Yield 2025 *
-
Free-Float 98.78%
More Fundamentals * Assessed data
Dynamic Chart
Axcelis Technologies, Inc. Announces the Resignation of Mary G. Puma from Board of Directors CI
North American Morning Briefing : Stock Futures -2- DJ
B, Riley Adjusts Axcelis Technologies Price Target to $155 From $165, Maintains Buy Rating MT
Transcript : Axcelis Technologies, Inc., Q1 2024 Earnings Call, May 02, 2024
Earnings Flash (ACLS) AXCELIS TECHNOLOGIES Posts Q1 Revenue $252.4M, vs. Street Est of $242.6M MT
Axcelis Technologies, Inc. Provides Financial Guidance for the Second Quarter Ending June 30, 2024 and Second Half of Fiscal 2024 CI
Axcelis Technologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Axcelis Technologies, Inc. Announces Shipment of 'Purion EXE SiC Power Series' Implanter and Successful 'Purion H200 SiC Power Series' Eval Closure At Leading Power Device Manufacturers in Japan CI
Axcelis Technologies, Inc. Announces Multiple Shipments of 150mm 'Purion M SiC Power Series' Implanters to Leading Power Device Manufacturers in China CI
Axcelis Technologies, Inc. Announces Board and Committee Appointments CI
B. Riley Adjusts Price Target on Axcelis Technologies to $165 From $180, Maintains Buy Rating MT
Top Midday Decliners MT
Sector Update: Tech Stocks Mixed Premarket Thursday MT
Transcript : Axcelis Technologies, Inc., Q4 2023 Earnings Call, Feb 08, 2024
Axcelis Technologies Q4 Earnings, Revenue Increase; Sets Q1, Fiscal 2024 Revenue Guidance; Shares Slump Pre-Bell MT
More news
1 day-1.05%
1 week+1.01%
1 month+8.66%
3 months-0.16%
6 months-9.49%
Current year-13.26%
More quotes
1 week
108.36
Extreme 108.36
115.87
1 month
99.73
Extreme 99.73
117.20
Current year
93.77
Extreme 93.77
145.77
1 year
93.77
Extreme 93.77
201.00
3 years
33.36
Extreme 33.36
201.00
5 years
12.99
Extreme 12.99
201.00
10 years
6.72
Extreme 6.72
201.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 16-10-30
Director of Finance/CFO 43 23-08-31
Chief Tech/Sci/R&D Officer - 23-05-31
Members of the board TitleAgeSince
Director/Board Member 63 Feb. 27
Director/Board Member 70 15-04-30
Director/Board Member 62 19-08-13
More insiders
Date Price Change Volume
24-05-31 112.5 -1.05% 484,048
24-05-30 113.7 +0.70% 293,805
24-05-29 112.9 -2.12% 397,896
24-05-28 115.3 +3.56% 468,704
24-05-24 111.4 +1.93% 349,677

Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT

More quotes
Axcelis Technologies, Inc. designs, manufactures and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. The Company offers a complete line of high energy, high current and medium current implanters for all application requirements. In addition to equipment, the Company provides extensive aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services and customer training. Its Purion flagship systems are all based on a common platform, which enables a combination of implant purity, precision and productivity. Combining a single wafer end station, with advanced spot beam architectures (that ensures all points across the wafer see the same beam condition at the same beam angle), Purion products enable process control to optimize device performance and yield, at high productivity. The Company sells its products to semiconductor chip manufacturers around the world.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
112.5 USD
Average target price
144 USD
Spread / Average Target
+28.01%
Consensus